1. Chorzelski TP et al: Immunofluorescence studies in the diagnosis of dermatitis herpetiformis and its differentiation from bullous pemphigoid. J Invest Dermatol 56:373-380, 1971
2. Chorzelski TP, Jablonska S, Maciejowska E: Linear IgA bullous dermatosis of adults. Clin Dermatol 9:383-392, 1991
3. Lawley TJ et al: Small intestinal biopsies and HLA types in dermatitis herpetiformis patients with granular and linear IgA skin deposits. J Invest Dermatol 74:9-12, 1980
4. Leonard JN et al: Linear IgA disease in adults. Br J Dermatol 107:301-316, 1982
5. Cohen DM et al: Linear IgA disease histopathologically and clinically masquerading as lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:196-201, 1999
6. Torchia D et al: Linear IgA disease presenting as prurigo nodularis. Br J Dermatol 155:479-480, 2006.
7. Armstrong AW et al: Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme. J Cutan Pathol 31:393-397, 2004
8. Baden LA et al: Vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol 124:1186-1188, 1988
9. Carpenter S et al: Vancomycin-associated linear IgA dermatosis. J Am Acad Dermatol 26:45-48, 1992
10. McWhirter JD et al: Linear IgA bullous dermatosis related to
lithium carbonate.
Arch Dermatol 123:1120-1122, 1987
11. Waldman MA, Black DR, Callen JP: Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Clin Exp Dermatol 29:633-636, 2004
12. Billet SE et al: A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol 144: 774-778, 2008
13. Khan I et al: Drug-associated linear IgA disease mimicking toxic epidermal necrolysis. Clin Exp Dermatol 34:715-717, 2009
14. Walsh SN, Kerchner K, Sanguexa OP: Localized palmar vancomycin-induced linear IgA bullous dermatosis occuring at supratherapeutic levels. Arch Dermatol 145(5):603-604, 2009
15. Chorzelski TP, Jablonska S: IgA linear dermatosis of childhood (chronic bullous disease of childhood). Br J Dermatol 101:535-542, 1979
16. Jablonska S et al: Linear IgA bullous dermatosis of childhood (Chronic bullous dermatosis of childhood). Clin Dermatol 9:393-401, 1992
17. Dabrowski J et al: The ultrastructural localization of IgA deposits in chronic bullous disease of childhood (CBDC). J Invest Dermatol 72:291-295, 1979
18. Zone JJ et al: Antigenic specificity of antibodies from patients with linear basement membrane deposition of IgA. Dermatology 189(Suppl.):64-66, 1994
19. Wojnarowska F, Bhogal BS, Black MM: Chronic bullous disease of childhood and linear IgA disease of adults are IgA1-mediated diseases. Br J Dermatol 131:201-204, 1994
20. Wojnarowska F et al: Chronic bullous disease of childhood, childhood cicatricial pemphigoid and linear IgA disease of adults: A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol 19:792-805, 1988
21. Collier PM et al: Adult Linear IgA disease and chronic bullous disease of childhood: The association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression. Br J Dermatol 141:867-875, 1999
22. Sachs JA et al: A comparative serological and molecular study of linear IgA diseaes and dermatitis herpetiformis. Br J Dermatol 118:759-764, 1988
23. Venning
VA et al: HLA type in bullous pemphigoid, cicatricial pemphigoid and linear IgA disease.
Clin Exp Dermatol 14:283-285, 1989
24. Flotte TJ et al: Immunopathologic studies of adult linear IgA bullous dermatosis. Arch Path Lab Med 109:457-459, 1985
25. Hall RP, Lawley TJ: Characterization of circulating and cutaneous IgA immune complexes in patients with dermatitis herpetiformis. J Immunol 135:1760-1765, 1985
26. Leonard JN et al: Evidence that the IgA in patients with linear IgA disease is qualitatively different from that of patients with dermatitis herpetiformis. Br J Dermatol 110:315-321, 1983
27. Wojnarowska F et al: The localization of the target antigens and antibodies in linear IgA disease is heterogenoeous and dependent on the methods used. Br J Dermatol 132:750-757, 1995
28. Karpati S et al: Ultrastructural immunogold studies in two cases oflinear IgA deramtosis. Are there two distinct types of this disease? Br J Dermatol 127:112-118, 1992
29. Prost C et al: Diagnosis of adult linear IgA dermatosis by immunoelectronmicroscopy in 16 patients with linear IgA deposits. J Invest Dermatol 92:39-45, 1989
30. Bhogal B et al: Linear IgA bullous dermatosis of adults and children: An immunoelectron microscopic study. Br J Dermatol 117:289-296, 1987
31. Horiguchi Y et al: Linear IgA dermatosis: Report of an infantile case and analysis of 213 cases in Japan. J Dermatol 35:737-743, 2008
32. Zone JJ et al: Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest 85:812-820, 1990
33. Ishiko A et al: 97-kDa linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane. J Invest Dermatol 106:739-743, 1996
34. Zone JJ et al: The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol 110:207-210, 1998
35. Roh JY et al: The 120 kDa soluble ectodomain of type XVII
collagen is recognized by autoantibodies in patinets with pemphigoid and linear IgA dermatosis.
Br J Dermatol 143:104-111, 2000
36. Schumann H et al: The shed ectodomain of
collagen XVII/BP 180 is targeted by autoantibodies in different blistering skin diseases.
Am J Pathol 156:685-695, 2000
37. Lin MS et al: Autoimmune responses in patients with linear IgA bullous dermatosis: Both autoantibodies and T lymphocytes recognize the NC16A domain of the BP 180 molecule. Clin Immunol 102:310-319, 2002
38. Zillikens D et al: Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP180. J Invest Dermatol 113:947-953, 1999
39. Wojnarowska F et al: Identification of the target antigen in chonic bullous disease of childhood and linear IgA diseae of adults. Br J Dermatol 124:157-162, 1991
40. Allen J, Wojnarowska F: Linear IgA disease: The IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults. Br J Dermatol 149:977-985, 2003
41. Ishii N et al: IgA autoantibodies against the NC16a domain of BP180 but not 120-KDa LAD-1 detected ina patient with linear IgA disease. Br J Dermatol 158:1151-1153, 2008
42. Peters MS, Rogers RS III. Clinical correlations of linear IgA deposition at the cutaneous basement membrane zone. J Am Acad Dermatol 20:761-770, 1989
43. Perrett CM, Evans AV, Russell-Jones R: Tea Tree oil dermatitis associated with linear IgA disease. Clin Exp Dermatol 28:167-170, 2003
44. Tran D, Kossard S, Shumack S: Phenytoin-induced linear IgA dermatosis mimicking toxic epidermal necrolysis. Australas J Dermatol 44:284-286, 2003
45. Blockmans D et al: Linear IgA dermatosis: A new cause of fever of unknown origin. Neth J Med 47:214-218, 1995
46. Leigh G, Marsden RA, Wojnarowska F: Linear IgA dermatosis with severe arthralgia. Br J Dermatol 119:789-792, 1988
47. Kelly SE et al: A clinicopathological study of mucosal involvement in linear IgA disease. Br J Dermatol 119:161-170, 1988
48. Leonard JN et al: The relationship between linear IgA disease and benign mucous membrane pemphigoid. Br J Dermatol 110:307-314, 1984
49. Porter SR, Bain SE, Scully CM: Linear IgA disease manifesting as recalcitrant desquamative gingivitis. Oral Surg 74:179-182, 1992
50. Sato K et al: Initial presentation and fatal complications of linear IgA bullous dermatosis in the larynx and pharynx. J Laryngol Otol 119:314-318, 2005
51. deFranchis R et al: Small-bowel involvement in dermatisi herpetiformis and in linear IgA bullous dermatosis. J Clin Gastroenterol 5:429-436, 1983
52. Leonard JN et al: Experience with a gluten free diet in the treatment of linear IgA disease. Acta Derm Venerol (Stockh) 67:145-148, 1987
53. Rose C et al: Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease. J Am Acad Dermatol 41:957-961, 1999
54. Birnie, AJ, Perkins W. A case of linear IgA disease occurring in a patient with colonic Crohn's disease. Br J Dermatol 153:1050-1052, 2005
55. Paige DG et al: Linear IgA disease and ulcerative colitis. Br J Dermatol 136:779-782, 1997
56. Smitt JHS et al: Chronic bullous disease of childhood and a paecilomyces lung infection in chronic granulomatous disease. Arch Dis Child 77:150-152, 1997
57. Alberta-Wszolek L et al: Linear IgA bullous dermatosis following influenza vaccination. Dermatol Online 15:3, 2009
58. Kociyigit P, Akay BN, Karaosmanoglu N: Linear IgA bullous dermatosis induced by interferon-alpha 2a. Clin Exp Dermatol 34:123-124, 2009
59. Palmer RA et al: Vancomycin-induced linear IgA disease with autoantiodies to BP180 and LAD 285. Br J Dermatol 145:816-820, 2001
60. Paul C et al: Drug-induced linear IgA disease: Target antigens are heterogeneous. Br J Dermatol 136:406-411, 1997
61. Joshi S, Scott G, Looney RJ: A successful challenge in a patient with vancomycin-induced linear IgA dermatosis. Ann Allergy Asthma Immunol 93:101-103, 2004
62. Godfrey K, Wojnarowska F, Leonard J: Linear IgA disease of adults: Association with lymphoproliferative malignancy and possible roel of other triggering factors. Br J Dermatol 123:447-452, 1990
63. McEvoy MT, Connolly SM: Linear IgA dermatosis: Association with malignancy. J Am Acad Dermatol 22:59-63, 1990
64. Blenkinsopp WK et al: Histology of linear IgA disease, dermatitis herpetiformis and bullous pemphigoid. Am J Dermatopathol 5:547-554, 1983
65. Smith SB et al: Linear IgA bullous dermatosis v dermatitis herpetiformis: Quantitiative measurements of dermoepidermal alterations. Arch Dermatol 120:324-328, 1984
66. Talhari C et al: Ocular linear IgA disease resulting in blindness. Arch Dermatol 142:766-767, 2006
67. Talhari C et al: Successful treatment of linear IgA diseae with
mycophenolate mofetil as a corticosteorid sparing agent.
Clin Exp Dermatol 30:297-298, 2005
68. Peterson JD, Chan LS: Linear IgA bullous dermatosis responsive to trimethoprim-sulfamethoxazole. Clin Exp Dermatol 32:756-758, 2007
69. Farley-Li J, Mancini AJ: Treatment of linear IgA bullous dermatosis of childhood with
mycophenolate mofetil.
Arch Dermatol 139:1121-1124, 2003
70. Goebeler M et al: Successful treatment of linear IgA disease with salazosupphapyridine and intravenous immunoglobulins. Br J Dermatol 149:912-914, 2003
71. Kroiss MM, Vogt M, Landthaler WS: High-dose intravenous immune globulin is also effective in linear IgA disease. Br J Dermatol 142:582, 2000
72. Dauendorffer JN, Mahé E, Saiag P:.
Tacrolimus ointment, an interesting adjunctive therapy for childhood linear IgA bullous dermatosis.
J Eur AcadDermatol Venereol 22(3):364-365, 2008
73. Cooper SM, Powell J, Wojnarowska F: Linear IgA disease: Successful treatment with
erythromycin.
Clin Exp Dermatol 27:677-679, 2002
74. Siegfried
EC, Sirawan S: Chronicbullous disease of childhood: Successful treatment with
dicloxacillin.
J Am Acad Dermatol 39:797-800, 1998
75. Alajlan A et al: Treatment of linear IgA bullous dermatosis of childhood with flucloxacillin. J Am Acad Dermatol 54:652-656, 2006